...

Merus N.V.

Visita il sito web

Informazioni sul datore di lavoro

Merus is a clinical-stage immuno-oncology company developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics®. Biclonics®, which are based on the full-length IgG format, are manufactured using industry standard processes and have been observed in preclinical studies to have similar features as conventional monoclonal antibodies, such as long half-life and low immunogenicity.

Sede del datore di lavoro

Trova datori di lavoro affini

...
University of Luxembourg Lussemburgo 100 posizioni aperte
...
KU Leuven Lovanio, Belgio 91 posizioni aperte
...
Eindhoven University of Technology Paesi Bassi 86 posizioni aperte
...
Ghent University Gand, Belgio 69 posizioni aperte
...
University of Twente Enschede, Paesi Bassi 62 posizioni aperte
Altri datori di lavoro

Questo potrebbe interessarti

...
5 Reasons to Pursue Your PhD at EMBL European Molecular Biology Laboratory (EMBL) 4 min. di lettura
...
The genetic detectives discovering who we really are University of Turku 5 min. di lettura
...
Deciphering the Gut’s Clues to Our Health University of Turku 5 min. di lettura
...
Understanding Users to Optimise 3D Experiences Centrum Wiskunde & Informatica (CWI) 5 min. di lettura
...
Harnessing the Rhizosphere to Protect Our Soil Free University of Bozen - Bolzano 5 min. di lettura
Altre storie